These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2941702)

  • 1. Evidence for the presence of D2 but not D1 dopamine receptors in rat hypothalamic perifornical area.
    Pizzi M; Coen E; Memo M; Missale C; Carruba MO; Spano PF
    Neurosci Lett; 1986 Jun; 67(2):159-62. PubMed ID: 2941702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of monoaminergic receptors in hypothalamic nuclei mediating feeding behavior in rats.
    Carruba MO; Nisoli E; Garosi V; Pizzi M; Memo M; Spano P
    J Pharmacol Exp Ther; 1991 Oct; 259(1):124-30. PubMed ID: 1681082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postsynaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries.
    Missale C; Pizzi M; Memo M; Picotti GB; Carruba MO; Spano PF
    Neurosci Lett; 1985 Oct; 61(1-2):207-11. PubMed ID: 2867503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol.
    Memo M; Pizzi M; Missale C; Carruba MO; Spano PF
    Neuropharmacology; 1987 May; 26(5):477-80. PubMed ID: 2955241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
    Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum.
    Olianas MC; Onali P
    J Neurochem; 1987 May; 48(5):1443-7. PubMed ID: 2951497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. II. Dorsal hippocampus.
    Grilli M; Nisoli E; Memo M; Missale C; Spano PF
    Neurosci Lett; 1988 May; 87(3):253-8. PubMed ID: 2898118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
    Starr M
    J Neurochem; 1987 Oct; 49(4):1042-9. PubMed ID: 2957468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptors mediating the stimulation and the inhibition of adenylate cyclase in rat prostate gland.
    Amenta D; Cavallotti C; Amenta F
    Neurosci Lett; 1987 Jun; 77(1):66-70. PubMed ID: 3037450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. I. Frontal cortex.
    Nisoli E; Grilli M; Memo M; Missale C; Spano PF
    Neurosci Lett; 1988 May; 87(3):247-52. PubMed ID: 2898117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum.
    Lucchi L; Moresco RM; Govoni S; Trabucchi M
    Brain Res; 1988 May; 449(1-2):347-51. PubMed ID: 2969275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization and characterization of dopamine D1 receptors in sheep hypothalamus and striatum.
    Colthorpe KL; Curlewis JD
    J Neuroendocrinol; 1996 Jul; 8(7):561-8. PubMed ID: 8843025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus.
    Missale G; Missale C; Sigala S; Cestari R; Memo M; Lojacono L; Spano P
    Life Sci; 1990; 47(5):447-55. PubMed ID: 1697642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aging on striatal dopamine receptor subtypes in Wistar rats.
    Henry JM; Filburn CR; Joseph JA; Roth GS
    Neurobiol Aging; 1986; 7(5):357-61. PubMed ID: 2946969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats.
    Onali P; Olianas MC; Gessa GL
    Eur J Pharmacol; 1984 Mar; 99(1):127-8. PubMed ID: 6233165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.